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To the Editor
We congratulate Sinha et al. on their recent report (1) comparing fecal sample collection 
methods for epidemiologic studies of the gut microbiome. These data contribute to the 
increasing body of literature describing robust methodological frameworks for specimen 
collection and processing (2, 3). However, their claim that fixation of stool using RNAlater® 
results in “considerable changes to the microbiome diversity” contrasts with previous 
findings (2, 3), including those from their earlier reports (4, 5). We have previously 
demonstrated that self-collected stool stabilized with RNAlater® or other fixatives yields 
high fidelity and reproducibility in compositional profiling of DNA and RNA from shotgun 
sequence data, compared to immediately-frozen specimens (3). Additionally, fixation offers 
several distinct advantages crucial for large-scale population-based studies: a straightforward 
self-collection procedure; sample stabilization without deep-freezing during shipping, 
receiving, and processing; and versatility for multiple molecular analyses. The authors’ 
finding that specimens preserved in RNAlater® had poor correlation with immediately 
frozen specimens (1) could be explained, for example, by improper fixation resulting from 
an excess of specimen relative to preservative volume (1–2 g:2.5 ml, compared to the 
manufacturer-recommended ratio of 1 g:5–10 ml; Thermo Fisher Scientific Inc., Waltham, 
MA).
Several key issues must be addressed before fecal occult blood test (FOBT) cards should be 
considered the “most practical collection device for field studies”, as the authors propose. 
First, while FOBT cards may have utility for 16S sequencing, can this method assure the 
stability of specimens for metatranscriptomic, metaproteomic, or metabolomic analyses that 
are likely to yield significantly richer biological insights? Second, the dietary (e.g. 
abstinence from red meat) and medication (e.g. avoidance of NSAIDs) modifications 
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required for FOBT collection within colorectal screening programs may impose undesirable 
limitations on gut microbiome studies. Lastly, as participant self-collection is the most 
feasible method for cohort studies at scale, how will environmental variation, such as 
ambient humidity and temperature during desiccation, or time between specimen collection, 
mailing, and eventual processing affect unfixed sample stability? These factors play 
important roles in gut microbial characterization for human populations, but none were 
addressed in the present study. Additionally, the rise in popularity of alternative non-invasive 
tools (e.g. fecal immunochemical testing) may threaten the long-term viability of guaiac 
FOBT cards for population-based colorectal screening. Therefore, despite their clinical track 
record and potential cost benefit, it is premature to recommend FOBT cards over more 
established and validated microbiome specimen collection protocols.
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